-
Mashup Score: 0Helixmith CEO vows to sell all his shares next year if trials fail - Pulse by Maeil Business News Korea - 3 year(s) ago
Kim Sun-young, CEO of South Korea��s gene therapy developer Helixmith Co., vowed to sell all of his treasury shares to recapitalize the company should it fail to succeed in clinical trials in its investigational therapies o
Source: pulsenews.co.krCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 5S Korea��s SK Telecom stands by Nanox investment - Pulse by Maeil Business News Korea - 4 year(s) ago
South Korea��s SK Telecom Co., the second-largest shareholder of Nanox, defended its investment in the Israeli medical imaging startup and reaffirmed its confidence in the company`s novel invention that has claimed to repla
Source: pulsenews.co.krCategories: Future of Medicine, Latest HeadlinesTweet
https://t.co/wAZsGdZYnU